Compare XBIT & HLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIT | HLP |
|---|---|---|
| Founded | 2005 | 2021 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.4M | 76.4M |
| IPO Year | 2015 | 2021 |
| Metric | XBIT | HLP |
|---|---|---|
| Price | $2.37 | $0.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 25.1K | ★ 622.2K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $51.63 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.09 | $0.34 |
| 52 Week High | $3.61 | $1.72 |
| Indicator | XBIT | HLP |
|---|---|---|
| Relative Strength Index (RSI) | 48.81 | 34.18 |
| Support Level | $2.35 | $0.38 |
| Resistance Level | $2.41 | $1.16 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 40.79 | 22.01 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Hongli Group Inc is a cold roll-formed steel profile manufacturer in China. It customizes and manufactures cold roll-formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation. Geographically, the company generates the majority of its revenue from the PRC.